je.st

Home › sanofi

Tag: sanofi

Sanofi shares plunge after diabetes drug warning

2014-10-28 13:48:29| Biotech - Topix.net

French drug maker Sanofi saw its stock price plunge Tuesday after it reported a slide in quarterly earnings and warned of pricing pressure on its blockbuster diabetes treatment in the U.S. Net profit slipped 2.4 percent in the third quarter as the maker of the Lantus diabetes treatment booked a higher charge for restructuring at its French operations. The drugmaker reported net profit of 1.9 billion euros in the third quarter, down from 1.22 billion euros a year earlier.

Tags: drug warning shares diabetes

US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteurs Investigational Pediatric Hexavalent Vaccine

2014-10-20 14:00:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. & SWIFTWATER, Pa. Phase III clinical study data presented at IDWeek in Philadelphia WHITEHOUSE STATION, N.J. & SWIFTWATER, Pa.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies investigational pediatric hexavalent vaccine, DTaP5-IPV-Hib-HepB1, has been accepted for review by the U.S. Food and Drug Administration (FDA). Language: English Contact: MerckMedia:Deb Wambold, (215) 652-2913orInvestors:Justin Holko, (908) 423-5088orSanofi PasteurMedia:Susan Watkins, (570) 957-2563susan.watkins@sanofipasteur.comorInvestors:George Grofik, (908) 981-5560IR@sanofi.com Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: SAN Exchange: BOURSE Ticker: SNY Exchange: NYSE read more

Tags: review application license accepts

France's Sanofi opens research hub in China

2014-09-25 15:33:12| Biotech - Topix.net

The Shanghai facility will research and develop products in four broad areas - biopharmaceuticals, vaccinations, disease and animal health - in cooperation with other global hubs, French pharmaceutical giant Sanofi said. CEO of Sanofi Chris Viehbacher and Cao Xuetao, president of the Chinese Academy of Social Sciences, attend the Sanofi Asia Pacific R&D Hub launching ceremony in Shanghai.

Tags: research china opens hub